Restructuring the ESRD payment system in the United States

Kidney International

Volumn 66, Issue 1, 2004, Pages 466-476

  Nissenson, Allen R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Dialysis; Medicare; Renal transplantation

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; INSULIN; PHOSPHORUS; RECOMBINANT ERYTHROPOIETIN; SEVELAMER;

ADULT; ANEMIA; BLOOD VESSEL CALCIFICATION; CASE REPORT; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DEBRIDEMENT; DIABETES MELLITUS; DIALYSIS; DISEASE COURSE; EMERGENCY WARD; FEMALE; GLUCOSE BLOOD LEVEL; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERPHOSPHATEMIA; HYPERTENSION; INJECTION PAIN; KIDNEY FAILURE; LEG ULCER; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

EID: 3042805156     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00753.x     Document Type: Review

References (56)

1. NISSENSON AR, RETTIG RA: Medicare's end-stage renal disease program: current status and future prospects. Health Aff 18:161-179, 1999
2. HULL AR: The legislative and regulatory process in the end-stage renal disease (ESRD) program, 1973 through 1997. Semin Nephrol 17:160-169, 1997
3. U.S. RENAL DATA SYSTEM: USRDS 2003 Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003
4. ANDERSON G, KNICKMAN JR: Changing the chronic care system to meet people's needs. Health Aff 20:146-160, 2001
5. WOLFF JL, STARFIELD B, ANDERSON G: Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162:2269-2276, 2002
6. CAPITMAN J: Effective coordination of medical and supportive services. J Aging Health 15:124-164, 2003
7. WAGNER EH, AUSTIN BT, DAVIS C, et al: Improving chronic illness care: Translating evidence into action. Health Aff 20:64-78, 2001
8. NISSENSON AR, COLLINS A, DICKMEYER J, et al: Evaluation of disease-state management of dialysis patients. Am J Kidney Dis 37:938-944, 2001
9. NISSENSON AR: Outcomes associated with a disease management program for end-state renal disease. Dis Man Health Outcomes 10(2):93-100, 2002
10. NISSENSON AR: Disease Management Improves Outcomes in Patients with CKD. Nephrology News Issues, August 2003
11. RETTIG RA, LEVINSKY NG: Kidney Failure and the Federal Government, Washington, DC, National Academy Press, 1991, pp 191-273
12. FARLEY DO: Financing of end-stage renal disease care: Past, present and future. Adv Ren Replace Ther 1:24-31, 1994
13. NISSENSON AR: Daily hemodialysis: Challenges and opportunities in the delivery and financing of end-stage renal disease patient care. Adv Ren Replace Ther 8:286-292, 2001
14. BRUNS FJ, SEDDON P, SAUL M, ZEIDEL ML: The cost of caring for end-stage kidney disease patients: an analysis based on hospital financial transaction records. J Am Soc Nephrol 9:884-890, 1998
15. PLOTH DW, SHEPP PH, COUNTS C, HUTCHISON F: Prospective analysis of global costs for maintenance of patients with ESRD. Am J Kidney Dis 42:12-21, 2003
16. RAY NF, ROSS M: Challenges and directions for Medicare ESRD payment policy. Semin Nephrol 20:565-576, 2000
17. RENAL PHYSICIANS ASSOCIATION/AMERICAN SOCIETY OF NEPHROLOGY: White Paper on the ESRD Payment System, document 3.02, July 20, 2002, www.renalmd.org
18. MEDICARE PAYMENT ADVISORY COMMISSION: Report to the Congress: Medicare Payment Policy (March 2001), Washington, D.C.
19. BEDDHU S, BRUNS FJ, SAUL M, et al: A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108:609-613, 2000
20. CHERTOW GM: Leveling the "paying" field in end-stage renal disease. Am J Med 108:666-667, 2000
21. EGGERS PW, FRANKENfIELD DL, GREER JW, MCCLELLAN W, OWEN WF, ROCCO MV: Comparison of mortality and intermediate outcomes between medicare dialysis patients in HMO and fee for service. Am J Kidney Dis 39:796-804, 2002
22. CENTERS FOR MEDICARE AND MEDICAID SERVICES: End stage renal disease (ESRD) program: ESRD managed care demonstration. www.cms.hhs.gov/esrd/6.asp, accessed 2003
23. INSTITUTE OF MEDICINE: Crossing the Quality Chasm, Washington, D.C., National Academy Press, 2001, pp 193-219
24. LOWRIE EG, TENG M, LACSON E, et al: Association between prevalent care process measures and facility-specific mortality rates. Kidney Int 60:1917-1929, 2001
25. MEDICARE PAYMENT ADVISORY COMMISSION. Report to the Congress: Medicare Payment Policy (March 2003), Washington, D.C.
26. CHERNEW ME, HIRTH RA, CUTLER DM. Increased spending on health care: How much can the United States afford? Health Aff 22:15-25, 2003
27. RETTIG RA: The politics of cost containment: end-stage renal disease. Bull NY Acad Med 56:115-138, 1980
28. WHITE AJ, MATTKE S, HASSOL A: Updating the 2002 Composite Rate for Dialysis Treatments, Cambridge, MA, Abt Associates Inc., 2001
29. GARG PP, POWE NR: Profit-making in the treatment of chronic kidney disease: Truth and consequences. Semin Dial 14:153-156, 2001
30. SZCZECH L, CHUA B, FRANKENFIELD D, et al: Dialysis facility profit status, dialysis care processes, and mortality in the CPM-USRDS dataset. J Am Soc Nephrol 2003 (in press)
31. HEALTH CARE FINANCING ADMINISTRATION: Final rule: Prospective Reimbursement for Dialysis Services. Fed Reg 48: 21254-21291, 1983
32. MOSLEY C: Coordination of care in disease management: Opportunities and financial issues. Semin Dial 13:346-350, 2000
33. HELD PJ, GARCIA JR, PAULY MV, CAHN MA: Price of dialysis, unit staffing, and length of dialysis treatment. Am J Kidney Dis 15:441-450, 1990
34. HORNBERGER JC: Economic consequences of alterations in the hemodialysis prescription. Semin Dial 7:299-303, 1994
35. HIRTH R, HELD P, ORZOL S, DOR A: Practice patterns, case mix, Medicare payment policy, and dialysis facility costs. Health Serv Res 33:1567-1592, 1999
36. SEHGAL AR: The incremental cost of providing adequate hemodialysis. Dial Transplant 32:526-534, 2003
37. WOLFE R, HIRTH R, WHEELER J, et al: An Expanded Medicare Out-patient End Stage Renal Disease Prospective Payment System: Phase 1 Report, Ann Arbor, MI, University of Michigan, Kidney Epidemiology and Cost Center, 2002
38. RPA/ASN Position Paper on the Nephrologist as Dialysis Facility Medical Director, document 4.01, March 26, 2001, www.renalmd.org
39. NATIONAL KIDNEY FOUNDATION. K/DOQI clinical practice guidelines for vascular access, 2000. Am J Kidney Dis 37:S137-S181, 2001
40. RPA/ASN Position Paper on Nephrologist Scope of Practice, document 1.98, April 27, 1998, www.renalmd.org
41. INSTITUTE OF MEDICINE: Leadership by Example, Washington, D.C., National Academy Press, 2003
42. DEPARTMENT OF HEALTH AND HUMAN SERVICES: Centers for Medicare and Medicaid Services: Medicare Program; Demonstration: End-stage renal disease - Disease Management, www.cms.hhs.gov/ esrd, accessed 2003
43. BURTON B, DAY LM, PIERPOINT KL, VLCHEK DL: Can a global payment system work for the ESRD program? Nephrol News Issues 7:18, 20, 22, 23, 1993
44. NISSENSON AR, PRICHARD SS, CHENG IKP, et al: Non-medical factors that impact on ESRD modality selection: Kidney Int 43 (Suppl 40):S120-127, 1993
45. NISSENSON AR, PRICHARD S, CHENG I, et al: ESRD modality selection into the 21st century: The importance of non medical factors. ASAIO J 43(3):143-150:1997
46. CHUGH KS, JHA V: Differences in the care of ESRD patients worldwide: Required resources and future outlook. Kidney Int 48:S7-S13, 1995
47. FRIEDMAN EA: Facing the reality: The world cannot afford uremia therapy at the start of the 21st century. Artif Organs 19:481-485, 1995
48. RIZVI A, AZIZ R, AHMED E, et al: Recruiting the community for supporting end-stage renal disease management in the developing world. Artif Organs 26:782-784, 2002
49. KHER V: Nephrology Forum: End-stage renal disease in developing countries. Kidney Int 62:350-362, 2002
50. BLENDON RJ, SCHOEN C, DESROCHES C, et al: Common concerns amid diverse systems: Health care experiences in five countries. Health Aff 22:106-121, 2003
51. DETSKY AS, NAYLOR CD: Canada's health care system-reform delayed. N Engl J Med 349:804-810, 2003
52. HIDAI H: Need for an incentive-based reimbursement policy toward quality care for dialysis patient management. Kidney Int 58:363-373, 2000
53. LEATHERMAN S, BERWICK D, ILES D, et al: The business case for quality: Case studies and an analysis. Health Aff 22:17-30, 2003
54. INSTITUTE OF MEDICINE: Crossing the Quality Chasm: A New Health System for the 21st Century, Washington, D.C., National Academy Press, 2001
55. BERRY LL, SEIDERS K, WILDER SS: Innovations in access to care: A patient-centered approach. Ann Intern Med 139:568-574, 2003
56. RPA White Paper on the Use of Performance-Based Incentives in Renal Care, approved March 24, 2003, www.renalmd.org